ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

BMRA Biomerica Inc

0.5529
-0.0371 (-6.29%)
2024年6月19日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Biomerica Inc BMRA NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.0371 -6.29% 0.5529 08:56:39
始値 安値 高値 終値 前日終値
0.5717 0.5326 0.5949 0.5316 0.59
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/1321:19GLOBEBiomerica Announces inFoods® IBS Pilot Launch with Prominent..
2024/5/1106:20EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/5/1106:15EDGAR2Form 8-K - Current report
2024/4/2921:19GLOBEBiomerica and Leading UAE Healthcare Company Forge a Path to..
2024/4/1520:47GLOBEBiomerica provides update on inFoods® IBS expansion
2024/4/1308:23GLOBEBiomerica Reports Third Quarter 2024 Financial Results
2024/3/2821:19GLOBEBiomerica InFoods IBS Data to be Presented at the Upcoming..
2024/2/2122:19GLOBEDiagnostics Industry Leader Gary Huff Appointed to Biomerica..
2024/2/1423:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1005:06EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/1/2322:19GLOBEDiagnostics Industry Leader Jack Kenny Appointed as Chairman..
2024/1/1622:19GLOBEBiomerica Reports Second Quarter 2024 Financial Results
2024/1/1621:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/12/1821:47GLOBEBiomerica Received US FDA 510(k) Clearance for Their Hp..
2023/12/1507:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1507:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1507:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1507:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1507:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1507:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1207:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1207:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1207:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1207:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1207:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1207:19EDGAR2Form 8-K - Current report
2023/12/1207:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1022:19GLOBEBiomerica to Participate in 14th Annual Craig-Hallum Alpha..
2023/11/0822:19GLOBEBiomerica Expands inFoods IBS Reach with Addition of Several..
2023/10/1402:10GLOBEREPEAT - Biomerica Reports First Quarter 2024 Financial..
2023/10/1319:39GLOBEBiomerica Reports First Quarter 2024 Financial Results
2023/10/1306:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/0213:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/9/2806:15EDGAR2Form DEF 14A - Other definitive proxy statements
2023/9/2621:19GLOBEDubai Government Grants Insurance Reimbursement for..
2023/9/2304:05GLOBEMaxim Group LLC to Host the Virtual Tech Conference Series:..
2023/9/2002:20EDGAR2Form 8-K - Current report
2023/8/2821:19GLOBEDiagnostics Industry Leader Jack Kenny Joins Biomerica’s..
2023/8/2821:10EDGAR2Form 8-K - Current report
2023/8/2606:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2023/8/2606:00GLOBEBiomerica Reports Fiscal 2023 Year End Results
2023/8/0321:19GLOBECVS Health to Begin Nationwide In-Store Sales of Biomerica’s..
2023/7/2705:46EDGAR2Form 8-K - Current report
2023/6/2121:19GLOBEBiomerica Receives Notice of Patent Allowance in China for a..

最近閲覧した銘柄

Delayed Upgrade Clock